Background: A high level of house dust mite (HDM) allergens in a living environment is a risk factor for both sensitization to these allergens and asthmatic attacks. We previously showed that plasma cluster ions (PCIs) impaired the IgE-binding capacity of atomized crude allergens prepared from Japanese cedar pollen and fungus under experimental conditions. Objective: We evaluated the capacity of PCIs to impair the IgE-binding capacity of airborne HDM allergens under a simulated indoor environmental condition. Methods: For the determination of the effects of PCIs on HDM allergens under an experimental condition, HDM extract was atomized as aqueous mist into a cylindrical experimental apparatus filled with PCIs. For the evaluation of the effects of PCIs under a simulated natural indoor environmental condition, dried HDM allergens were floated as airborne particles in an acryl cubic apparatus in the presence of PCIs. The IgE-binding capacities of the PCI- and sham-treated HDM allergens were analyzed by an ELISA. Results: The IgE-binding capacity of the HDM allergens was significantly impaired after PCI treatment compared to that after sham treatment under both experimental and simulated environmental conditions. The ELISA results demonstrated that the IgE-binding capacities of HDM allergens after PCI treatment showed 68 and 74% reductions compared to those after sham treatment under the experimental and simulated environmental conditions, respectively. Conclusions: PCIs have the capacity to impair the IgE-binding capacity of airborne HDM allergens in a simulated environmental condition.

1.
Brozek G, Lawson J, Szumilas D, Zejda J: Increasing prevalence of asthma, respiratory symptoms, and allergic diseases: four repeated surveys from 1993-2014. Respir Med 2015;109:982-990.
2.
Halken S, Høst A, Niklassen U, Hansen LG, Nielsen F, Pedersen S, Osterballe O, Veggerby C, Poulsen LK: Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J Allergy Clin Immunol 2003;111:169-176.
3.
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178.
4.
Casas L, Sunyer J, Tischer C, Gehring U, Wickman M, Garcia-Esteban R, Lehmann I, Kull I, Reich A, Lau S, Wijga A, Antó JM, Nawrot TS, Heinrich J, Keil T, Torrent M: Early-life house dust mite allergens, childhood mite sensitization, and respiratory outcomes. Allergy 2015;70:820-827.
5.
Qi S, Chen H, Huang N, Li W, Liu G, Wang Y, Hu L, Wang X, Zhang W, Zhu R: Early intervention improves clinical reponses to house dust mite immunotherapy in allergic rhinitis patients. Int Arch Allergy Immunol 2016;171:234-240.
6.
Becker S, Schlederer T, Kramer MF, Haack M, Vrtala S, Resch Y, Lupinek C, Valenta R, Gröger M: Real-life study for the diagnosis of house dust mite allergy - the value of recombinant allergen-based IgE serology. Int Arch Allergy Immunol 2016;170:132-137.
7.
Wang HY, Gao ZS, Zhou X, Dai Y, Yao W, Zhang XF, Yang ZW, Wu SD, Yu CH, Yang XY, van Ree R: Evaluation of the role of IgE responses to Der p 1 and Der p 2 in Chinese house dust mite-allergic patients. Int Arch Allergy Immunol 2015;167:203-210.
8.
Koehler C, Paulus M, Ginzkey C, Hackenberg S, Scherzad A, Ickrath P, Hagen R, Kleinsasser N: The proinflammatory potential of nitrogen dioxide and its influence on the house dust mite allergen Der p 1. Int Arch Allergy Immunol 2016;171:27-35.
9.
Kawamoto S, Oshita M, Fukuoka N, Shigeta S, Aki T, Hayashi T, Nishikawa K, Ono K: Decrease in the allergenicity of Japanese cedar pollen allergen by treatment with positive and negative cluster ions. Int Arch Allergy Immunol 2006;141:313-321.
10.
Nishikawa K, Fujimura T, Ota Y, Abe T, ElRamlawy KG, Nakano M, Takado T, Uenishi A, Kawazoe H, Sekoguchi Y, Tanaka A, Ono K, Kawamoto S: Exposure to positively- and negatively-charged plasma cluster ions impairs IgE-binding capacity of indoor cat and fungal allergens. World Allergy Organ J 2016;9:27.
11.
Nojima H, Nishikawa K: Air purification technology using ions generated by discharge plasma at atmospheric pressure (in Japanese). J Inst Electrostat Jpn 2002;26:153-157.
12.
Digel I, Temiz Artmann A, Nishikawa K, Cook M, Kurulgan E, Artmann GM: Bactericidal effects of plasma-generated cluster ions. Med Biol Eng Comput 2005;43:800-807.
13.
Takasawa H, Wako K, Sato Y, Takashima R, Hattori A, Kawabata M, Tsuchitani M, Wako Y, Yamada N, Hamada S: Air containing ions generated by electric discharge has no potential to induce DNA damage in lung cells in rats and mice. Genes Environ 2011;33:96-102.
14.
Yamamoto D, Wako Y, Kumabe S, Wako K, Sato Y, Fujishiro M, Yasuda Y, Matsuura I, Ohnishi Y: Positive and negative ions by air purifier have no effects on reproductive function or postnatal growth and development in rats. Fundam Toxicol Sci 2015;2:101-110.
15.
Aki T, Ono K, Paik SY, Wada T, Jyo T, Shigeta S, Murooka Y, Oka S: Cloning and characterization of cDNA coding for a new allergen from the house dust mite, Dermatophagoides farinae. Int Arch Allergy Immunol 1994;103:349-356.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.